YRC Logo
PROTEIN SEARCH:
Descriptions Names[Advanced Search]

Protein Overview: CDK2

General Information:
Name(s) found: CDK2 [HGNC (HUGO)]
Description(s) found:
SHOW ONLY BEST
  • gi|93278980|pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278978|pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278976|pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278972|pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278970|pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278968|pdb|2C5T|C Chain C, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278966|pdb|2C5T|A Chain A, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278964|pdb|2C5P|C Chain C, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278962|pdb|2C5P|A Chain A, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278960|pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278958|pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278956|pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • gi|93278954|pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI NR]
  • pir||A41227 protein kinase (EC 2.7.1.37) cdk2 - human [NCBI NR]
  • gi|88191970|pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9- Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor [NCBI NR]
  • gi|88191823|pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine Inhibitor [NCBI NR]
  • gi|8569330|pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The Inhibitor Hymenialdisine [NCBI NR]
  • gi|85544571|pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine [NCBI NR]
  • gi|85544368|pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The Triazolopyrimidine Inhibitor [NCBI NR]
  • gi|85544367|pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The Triazolopyrimidine Inhibitor [NCBI NR]
  • gi|85544366|pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The Triazolopyrimidine Inhibitor [NCBI NR]
  • gi|85544365|pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The Triazolopyrimidine Inhibitor [NCBI NR]
  • gi|85544364|pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The Triazolopyrimidine Inhibitor [NCBI NR]
  • gi|85544363|pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The Triazolopyrimidine Inhibitor [NCBI NR]
  • gi|85544362|pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The Triazolopyrimidine Inhibitor [NCBI NR]
  • gi|83754434|pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032 [NCBI NR]
  • gi|83754433|pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873 [NCBI NR]
  • gi|82408005|pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Indenopyraxole Din-101312 [NCBI NR]
  • gi|82408004|pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din- 232305 [NCBI NR]
  • gi|82408003|pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din- 234325 [NCBI NR]
  • gi|82408002|pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph- 042562 [NCBI NR]
  • gi|6729909|pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With Cell Cycle-Regulatory Protein Ckshs1 [NCBI NR]
  • gi|6729776|pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Purvalanol B [NCBI NR]
  • gi|62738959|pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine [NCBI NR]
  • gi|62738958|pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The Inhibitor 5-Bromo-Indirubine [NCBI NR]
  • gi|61680548|pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Pyrazolo[1, 5-A]pyrimidine Inhibitor [NCBI NR]
  • gi|61680547|pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Pyrazolo[1, 5-A]pyrimidine Inhibitor [NCBI NR]
  • gi|60593882|pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography [NCBI NR]
  • gi|60593775|pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The Inhibitor Olomoucine. [NCBI NR]
  • gi|56554234|pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly [NCBI NR]
  • gi|56554232|pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly [NCBI NR]
  • gi|51247206|pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor [NCBI NR]
  • gi|50514021|pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227 [NCBI NR]
  • gi|48425226|pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- N',N'-Dimethyl-Benzene-1,4-Diamine [NCBI NR]
  • gi|48425225|pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2- Yl]-(3-Nitro-Phenyl)-Amine [NCBI NR]
  • gi|48425224|pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)- Pyrimidin-2-Ylamino]-Phenol [NCBI NR]
  • gi|48425223|pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2- Ylamino]-Phenol [NCBI NR]
  • gi|42543514|pdb|1R78|A Chain A, Cdk2 Complex With A 4-Alkynyl Oxindole Inhibitor [NCBI NR]
  • gi|40889337|pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine [NCBI NR]
  • gi|40889336|pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor N-[4-(2,4-Dimethyl-Thiazol-5-Yl)pyrimidin-2-Yl]- N'-Hydroxyiminoformamide [NCBI NR]
  • gi|40889335|pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine [NCBI NR]
  • gi|40889334|pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2- Ylamine [NCBI NR]
  • gi|40889331|pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2 [NCBI NR]
  • gi|40889233|pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Asn- (P-F-Phe)-Nh2 [NCBI NR]
  • gi|40889231|pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Asn- (P-F-Phe)-Nh2 [NCBI NR]
  • gi|40889229|pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor H-Cit-Cit-Leu-Ile- (P-F-Phe)-Nh2 [NCBI NR]
  • gi|40889227|pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor H-Cit-Cit-Leu-Ile- (P-F-Phe)-Nh2 [NCBI NR]
  • gi|40889223|pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor Ac-Arg-Arg-Leu-Asn- (M-Cl-Phe)-Nh2 [NCBI NR]
  • gi|40889221|pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor Ac-Arg-Arg-Leu-Asn- (M-Cl-Phe)-Nh2 [NCBI NR]
  • gi|40889217|pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Ile-Phe-Nh2 [NCBI NR]
  • gi|40889215|pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Ile-Phe-Nh2 [NCBI NR]
  • gi|40889211|pdb|1OKU|C Chain C, Cyclin A Binding Groove Inhibitor H-Ala-Ala-Abu-Arg-Er-Leu-Ile-(P-F-Phe)-Nh2 [NCBI NR]
  • gi|40889209|pdb|1OKU|A Chain A, Cyclin A Binding Groove Inhibitor H-Ala-Ala-Abu-Arg-Er-Leu-Ile-(P-F-Phe)-Nh2 [NCBI NR]
  • gi|34811494|pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A Trisubstituted Naphthostyril Inhibitor [NCBI NR]
  • gi|33356978|pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine [NCBI NR]
  • gi|33356977|pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The Inhibitor 2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine [NCBI NR]
  • gi|30582481|gb|AAP35467.1| cyclin-dependent kinase 2 [Homo sapiens] [NCBI NR]
  • gi|2624601|pdb|1AQ1| Chain , Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Staurosporine [NCBI NR]
  • gi|239781731|pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2, Cyclin A Through Structure Guided Design [NCBI NR]
  • gi|239781728|pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2, Cyclin A Through Structure Guided Design [NCBI NR]
  • gi|239781726|pdb|2WHA|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2, Cyclin A Through Structure Guided Design [NCBI NR]
  • gi|239781724|pdb|2WHA|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2, Cyclin A Through Structure Guided Design [NCBI NR]
  • gi|239781674|pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2, Cyclin A Through Structure Guided Design [NCBI NR]
  • gi|239781672|pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2, Cyclin A Through Structure Guided Design [NCBI NR]
  • gi|239781670|pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2, Cyclin A Through Structure Guided Design [NCBI NR]
  • gi|239781668|pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2, Cyclin A Through Structure Guided Design [NCBI NR]
  • gi|228151|prf||1717387A cyclin A dependent p33 kinase:SUBUNIT=2 [NCBI NR]
  • gi|226438308|pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To Human Cyclin-Dependent Kinase-2 (Cdk-2) [NCBI NR]
  • gi|222447073|pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At Its Active Site [NCBI NR]
  • gi|222447071|pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At Its Active Site [NCBI NR]
  • gi|222142987|pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea (At9283), A Multi-Targeted Kinase Inhibitor With Potent Aurora Kinase Activity [NCBI NR]
  • gi|21465823|pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4- ({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-2- Oxo-2,3-Dihydro-1h-Indole [NCBI NR]
  • gi|21465822|pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 4-{[(2-Oxo- 1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3- Thiazol-2-Yl)benzenesulfonamide [NCBI NR]
  • gi|21465821|pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2- Dioxido-1,3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5- (1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One [NCBI NR]
  • gi|21465820|pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With N-Methyl-{4- [2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8- Ylidene)hydrazino]phenyl}methanesulfonamide [NCBI NR]
  • gi|21465819|pdb|1KE5|A Chain A, Cdk2 Complexed With N-Methyl-4-{[(2-Oxo-1,2-Dihydro-3h- Indol-3-Ylidene)methyl]amino}benzenesulfonamide [NCBI NR]
  • gi|211939398|pdb|3EOC|C Chain C, Cdk2CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-Amine [NCBI NR]
  • gi|211939396|pdb|3EOC|A Chain A, Cdk2CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-Amine [NCBI NR]
  • gi|21105793|gb|AAM34794.1|AF512553_1 cyclin-dependent kinase 2 [Homo sapiens] [NCBI NR]
  • gi|209870533|pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR [NCBI NR]
  • gi|209870531|pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR [NCBI NR]
  • gi|209870529|pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR [NCBI NR]
  • gi|209870527|pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR [NCBI NR]
  • gi|209447378|pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl Pyrimidine, Compound 5b [NCBI NR]
  • gi|206581812|pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl Pyrimidine, Compound 5c [NCBI NR]
  • gi|198443068|pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2 [NCBI NR]
  • gi|195927351|pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine [NCBI NR]
  • gi|195927341|pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927340|pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927339|pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927338|pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927337|pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927336|pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927335|pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927334|pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927333|pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927332|pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927331|pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927330|pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927329|pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|195927328|pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI NR]
  • gi|1942965|pdb|1HCL| Chain , Human Cyclin-Dependent Kinase 2 [NCBI NR]
  • gi|1942964|pdb|1HCK| Chain , Human Cyclin-Dependent Kinase 2 [NCBI NR]
  • gi|1942429|pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex [NCBI NR]
  • gi|1942427|pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex [NCBI NR]
  • gi|18655410|pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor [NCBI NR]
  • gi|18158854|pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In Complex With Pkf049-365 [NCBI NR]
  • gi|180178|gb|AAA35667.1| cdc2-related protein kinase [NCBI NR]
  • gi|16974882|pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2 (Cdk2) In Complex With The Inhibitor H717 [NCBI NR]
  • gi|16936528|ref|NP_001789.2| cyclin-dependent kinase 2 isoform 1 [Homo sapiens] [NCBI NR]
  • gi|166235433|pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding Groove Inhibitors [NCBI NR]
  • gi|166235431|pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding Groove Inhibitors [NCBI NR]
  • gi|166007157|pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With Inhibitor [NCBI NR]
  • gi|166007147|pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With Inhibitor [NCBI NR]
  • gi|166007146|pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With Inhibitor [NCBI NR]
  • gi|166007145|pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With Inhibitor [NCBI NR]
  • gi|160285605|pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic Aminopyrimidine [NCBI NR]
  • gi|15826626|pdb|1JSV|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In Complex With 4-[(6-Amino-4-Pyrimidinyl) Amino]benzenesulfonamide [NCBI NR]
  • gi|158257314|dbj|BAF84630.1| unnamed protein product [Homo sapiens] [NCBI NR]
  • gi|157880459|pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino Pyrimidine Cdk4 Inhibitor [NCBI NR]
  • gi|157880424|pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine [NCBI NR]
  • gi|157879505|pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin- Dependent Kinase Inhibitors Identified Through Structure- Based Hybridisation [NCBI NR]
  • gi|157878069|pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor [NCBI NR]
  • gi|157878068|pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino Pyrimidine Cdk4 Inhibitor [NCBI NR]
  • gi|157878067|pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino Pyrimidine Cdk4 Inhibitor [NCBI NR]
  • gi|157874291|pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Nu6027 [NCBI NR]
  • gi|157874285|pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Nu2058 [NCBI NR]
  • gi|157838228|pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160 [NCBI NR]
  • gi|157838227|pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2 [NCBI NR]
  • gi|157831293|pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2 [NCBI NR]
  • gi|157831292|pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2 [NCBI NR]
  • gi|157830015|pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Staurosporine [NCBI NR]
  • gi|151568097|pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone Inhibitor [NCBI NR]
  • gi|151568095|pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone Inhibitor [NCBI NR]
  • gi|151568094|pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone Inhibitor [NCBI NR]
  • gi|145580555|pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding Groove Inhibitors [NCBI NR]
  • gi|145580553|pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding Groove Inhibitors [NCBI NR]
  • gi|13111756|gb|AAH03065.1| Cyclin-dependent kinase 2 [Homo sapiens] [NCBI NR]
  • gi|13096585|pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE Inhibitor [NCBI NR]
  • gi|13096583|pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE Inhibitor [NCBI NR]
  • gi|13096582|pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In Complex With An Oxindole Inhibitor [NCBI NR]
  • gi|126030317|pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones [NCBI NR]
  • gi|12084191|pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin Complexed To Human Cyclin Dependent Kinase 2 [NCBI NR]
  • gi|12084189|pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin Complexed To Human Cyclin Dependent Kinase 2 [NCBI NR]
  • gi|119617266|gb|EAW96860.1| cyclin-dependent kinase 2, isoform CRA_b [Homo sapiens] [NCBI NR]
  • gi|119617264|gb|EAW96858.1| cyclin-dependent kinase 2, isoform CRA_b [Homo sapiens] [NCBI NR]
  • gi|119389072|pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar Study, Crystal Structure In Complex With Cdk2, Selectivity, And Cellular Effects [NCBI NR]
  • gi|118138191|pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE Inhibitor [NCBI NR]
  • gi|118138189|pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE Inhibitor [NCBI NR]
  • gi|118137772|pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine Inhibitor [NCBI NR]
  • gi|116666717|pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With Roscovitine [NCBI NR]
  • gi|116051|sp|P24941.2|CDK2_HUMAN RecName: Full=Cell division protein kinase 2; AltName: Full=p33 protein kinase [NCBI NR]
  • gi|11513302|pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In Complex With 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline [NCBI NR]
  • cyclin-dependent kinase 2 [HGNC (HUGO)]
  • Cyclin-dependent kinase 2 OS=Homo sapiens GN=CDK2 PE=1 SV=2 [Swiss-Prot]
  • Cell division protein kinase 2 [hmr_yeast5_DM3-1_pombe.fasta]
  • cyclin-dependent kinase 2 isoform 1; cdc2-related protein kinase; cell devision kinase 2; p33 protein kinase [HMR_022704.fasta]
  • cyclin-dependent kinase 2 isoform 1 [Homo sapiens]gi|30582481|gb|AAP35467.1| cyclin-dependent kinase 2 [Homo sapiens]gi|13111756|gb|AAH03065.1| Cyclin-dependent kinase 2, isoform 1 [Homo sapiens]gi|21105793|gb|AAM34794.1| cyclin-dependent kinase 2 [Hom [nrdb_11152004_Chlamydomonas]
  • Cell division protein kinase 2 (p33 protein kinase) [Yateslab_human_na_07-28-2006_reversed.fasta]
  • Tax_Id=9606 Cell division protein kinase 2 [EBI-IPI_human_3.17_05-09-2006_con_reversed.fasta]
  • (NM_001798) cyclin-dependent kinase 2, isoform 1; cdc2-related protein kinase; cell devision kinase 2; p33 protein kinase [Homo sapiens] [NCBI-RefSeq_human-mouse-rat_na_10-18-2006_con_reversed.fasta]
  • cyclin-dependent kinase 2 isoform 1 [Homo sapiens] [NCBI-RefSeq_Human_na_12_06_2006_con_reversed.fasta]
  • cyclin-dependent kinase 2 isoform 1; cdc2-related protein kinase; cell devision kinase 2; p33 protein kinase [Homo sapiens] [HumanGallus06162005.fasta]
  • Chain A, Cdk2 In Complex With An Imidazole Piperazine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519), A Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-Ray Crystallography And Structure Based Drug Design. [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding Groove Inhibitors [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding Groove Inhibitors [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic Aminopyrimidine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino Pyrimidine Cdk4 Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin- Dependent Kinase Inhibitors Identified Through Structure- Based Hybridisation [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Nu6027 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Nu2058 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin-Dependent Kinase 2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Staurosporine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Structure Of Cdk2 With A 3-Hydroxychromones [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar Study, Crystal Structure In Complex With Cdk2, Selectivity, And Cellular Effects [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin-Dependent Kinase 2 In Complex With Roscovitine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9- Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cdk2 In Complex With Isopentenyladenine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of The Human Cdk2 Complexed With The Triazolopyrimidine Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of Human Cdk2 Complexed With A Pyrazolo[1, 5-A]pyrimidine Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Screening For Fragment Binding By X-Ray Crystallography [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Crystals Structure Of Human Cdk2 In Complex With The Inhibitor Olomoucine. [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-Phe-Gly [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-Phe-Gly [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of Cdk2 With Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Structure Of Cdk2 Complexed With Pnu-181227 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- N',N'-Dimethyl-Benzene-1,4-Diamine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2- Yl]-(3-Nitro-Phenyl)-Amine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)- Pyrimidin-2-Ylamino]-Phenol [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2- Ylamino]-Phenol [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cdk2 Complex With A 4-Alkynyl Oxindole Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor N-[4-(2,4-Dimethyl-Thiazol-5-Yl)pyrimidin-2-Yl]- N'-Hydroxyiminoformamide [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2- Ylamine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Asn-(P-F- Phe)-Nh2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Asn-(P-F- Phe)-Nh2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Cyclin A Binding Groove Inhibitor H-Cit-Cit-Leu-Ile-(P-F- Phe)-Nh2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin A Binding Groove Inhibitor H-Cit-Cit-Leu-Ile-(P-F- Phe)-Nh2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Cyclin A Binding Groove Inhibitor Ac-Arg-Arg-Leu-Asn-(M-Cl- Phe)-Nh2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin A Binding Groove Inhibitor Ac-Arg-Arg-Leu-Asn-(M-Cl- Phe)-Nh2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Ile-Phe-Nh2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Ile-Phe-Nh2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A Trisubstituted Naphthostyril Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The Inhibitor 2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4- ({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-2- Oxo-2,3-Dihydro-1h-Indole [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 4-{[(2-Oxo- 1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3- Thiazol-2-Yl)benzenesulfonamide [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2- Dioxido-1,3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5- (1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With N-Methyl-{4- [2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8- Ylidene)hydrazino]phenyl}methanesulfonamide [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cdk2 Complexed With N-Methyl-4-{[(2-Oxo-1,2-Dihydro-3h- Indol-3-Ylidene)methyl]amino}benzenesulfonamide [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In Complex With Pkf049-365 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2 (Cdk2) In Complex With The Inhibitor H717 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In Complex With 4-[(6-Amino-4-Pyrimidinyl) Amino]benzenesulfonamide [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In Complex With An Oxindole Inhibitor [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin Complexed To Human Cyclin Dependent Kinase 2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin Complexed To Human Cyclin Dependent Kinase 2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In Complex With 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The Inhibitor Hymenialdisine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With Cell Cycle-Regulatory Protein Ckshs1 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Structure Of Cdk2 Complexed With Pnu-198873 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Indenopyraxole Din-101312 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din- 232305 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din- 234325 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph- 042562 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The Inhibitor 5-Bromo-Indirubine [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Purvalanol B [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • unnamed protein product [Homo sapiens] [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • cyclin-dependent kinase 2, isoform CRA_b [Homo sapiens] [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Cyclin-dependent kinase 2 [Homo sapiens] [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • cyclin-dependent kinase 2 [Homo sapiens] [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • cyclin A dependent p33 kinase:SUBUNIT=2 [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • cdc2-related protein kinase [NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
  • Tax_Id=9606 CELL DIVISION PROTEIN KINASE 2 [Xentr4_EBI-IPI_human_mouse_rat_Xenopus_tropicalis_laevis_con_reversed.fasta]
  • Chain A, Structure Of Cdk2 In Complex With An Imidazolyl Pyrimidine, Compound 5c [NCBI-RefSeq_human_na_10-15-2008_con_reversed.fasta]
  • Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2 [NCBI-RefSeq_human_na_10-15-2008_con_reversed.fasta]
  • Tax_Id=9606 Gene_Symbol=CDK2 Cell division protein kinase 2 [human-ipi-250309-contam.fasta]
  • Chain C, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [nr-271106-contam.fasta]
  • Chain A, Cyclin A Binding Groove Inhibitor H-Cit-Cit-Leu-Ile- (P-F-Phe)-Nh2 [nr-271106-contam.fasta]
  • Chain C, Cyclin A Binding Groove Inhibitor Ac-Arg-Arg-Leu-Asn- (M-Cl-Phe)-Nh2 [nr-271106-contam.fasta]
  • Chain C, Cyclin A - Cyclin-Dependent Kinase 2 Complex [nr-271106-contam.fasta]
  • Chain , Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor Staurosporine [nr-271106-contam.fasta]
  • Chain A, Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design [nr-271106-contam.fasta]
  • Chain C, Cyclin A Binding Groove Inhibitor H-Cit-Cit-Leu-Ile- (P-F-Phe)-Nh2 [nr-271106-contam.fasta]
  • Chain A, Cyclin A - Cyclin-Dependent Kinase 2 Complex [nr-271106-contam.fasta]
  • Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly [nr-271106-contam.fasta]
  • Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly [nr-271106-contam.fasta]
  • Chain A, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Asn- (P-F-Phe)-Nh2 [nr-271106-contam.fasta]
  • Chain , Human Cyclin-Dependent Kinase 2 [nr-271106-contam.fasta]
  • Chain C, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Asn- (P-F-Phe)-Nh2 [nr-271106-contam.fasta]
  • Chain A, Structure Of Cdk2 Complexed With Pnu-230032 [nr-271106-contam.fasta]
  • Chain A, Cyclin A Binding Groove Inhibitor Ac-Arg-Arg-Leu-Asn- (M-Cl-Phe)-Nh2 [nr-271106-contam.fasta]
  • IPI:IPI00031681.1|SWISS-PROT:P24941|TREMBL:A8K7C6|ENSEMBL:ENSP00000266970|REFSEQ:NP_001789|H-INV:HIT000196192|VEGA:OTTHUMP00000167955 Tax_Id=9606 Gene_Symbol=CDK2 Cell division protein kinase 2 [ipi.HUMAN.fasta.20090807]
  • [human_BMb_040710_contam.fasta]
  • Tax_Id=9606 Gene_Symbol=CDK2 Cell division protein kinase 2 ENSG00000123374 IPI00260318 IPI00031681 IPI00797954 [drosphohumanreversed.fasta]
  • cell division protein kinase 2 isoform 1 [Homo sapiens] [NCBI-RefSeq_Human_na_04-23-2010_reversed.fasta]
  • Cell division protein kinase 2 OS=Homo sapiens GN=CDK2 PE=1 SV=2 [UniProtHuman070710.fasta]
  • P24941;A8K7C6; RecName: Full=Cell division protein kinase 2; AltName: Full=p33 protein kinase; [UniProt_Human_2010_06_06-01-2010_reversed.fasta]
  • Cell division protein kinase 2 OS=Homo sapiens GN=CDK2 [011711_HMR.fasta]
  • IPI:IPI00031681.1|SWISS-PROT:P24941|ENSEMBL:ENSP00000266970|REFSEQ:NP_001789|H-INV:HIT000196192|VEGA:OTTHUMP00000167955 Tax_Id=9606 Gene_Symbol=CDK2 Cell division protein kinase 2 [ipi.HUMAN.fasta.20100406]
  • GeneSymbol=CDK2 Synonyms=p33(CDK2) cell division protein kinase 2 isoform 1 [Homo sapiens] [NCBI-RefSeq_Human_Seno_07-12-2011_reversed.fasta]
  • Cyclin-dependent kinase 2 OS=Homo sapiens GN=CDK2 [122011_hum.fasta]
  • IPI:IPI00031681.1|SWISS-PROT:P24941|ENSEMBL:ENSP00000266970|REFSEQ:NP_001789|H-INV:HIT000196192 Tax_Id=9606 Gene_Symbol=CDK2 Cyclin-dependent kinase 2 [ipi.HUMAN.20110912.fasta]
  • Cyclin-dependent kinase 2 GN=CDK2 [Doctor+uniprot-HUMAN-120911.fasta]
  • Tax_Id=9606 Gene_Symbol=CDK2 Cyclin-dependent kinase 2 [human-ipi-270911-contam-BSA.fasta]
  • Cyclin-dependent kinase 2, isoform CRA_b OS=Homo sapiens GN=CDK2 PE=4 SV=1 [uniprot-human-031015-contam.fasta]
    • Organism: Homo sapiens
    Length: 298 amino acids

    Gene Ontology:
    Cellular Component: NONE FOUND
    Biological Process: NONE FOUND
    Molecular Function: NONE FOUND


    Sequence:
    Sequence:
    [PDR BLAST]
    [ProtParam] 
          1          11         21         31         41         51         
      |          |          |          |          |          |          
    1 MENFQKVEKI GEGTYGVVYK ARNKLTGEVV ALKKIRLDTE TEGVPSTAIR EISLLKELNH  60
   61 PNIVKLLDVI HTENKLYLVF EFLHQDLKKF MDASALTGIP LPLIKSYLFQ LLQGLAFCHS 120
  121 HRVLHRDLKP QNLLINTEGA IKLADFGLAR AFGVPVRTYT HEVVTLWYRA PEILLGCKYY 180
  181 STAVDIWSLG CIFAEMVTRR ALFPGDSEID QLFRIFRTLG TPDEVVWPGV TSMPDYKPSF 240
  241 PKWARQDFSK VVPPLDEDGR SLLSQMLHYD PNKRISAKAA LAHPFFQDVT KPVPHLRL

    Protein Complex Data

    No complex found for this protein.

    Mass Spectrometry Data

    No mass spectrometry results found for this protein.

    Yeast Two-Hybrid Data

    The following interactions contain this protein:

    SHOWING SINGLE HITS. [ Hide Single Hits ]

    [View our yeast two-hybrid interpretation guidelines.]

    No yeast two-hybrid interactions found for this protein.

    Microscopy / Localization Data

    New Feature: Upload Your Own Microscopy Data

    No microscopy data found in the PDR for this protein.

    Protein Structure Data


    [What does the above image mean?]
    [View Top Sequence Alignments] [Show Ginzu Version Information]

    Domains predicted:

    #   Region(s) Method Confidence Match Description
    1 View Details [1..298] PSI-BLAST 107.0 No description for 2iw8A was found.

    Functions predicted (by domain):

    # Gene Ontology predictions
    1
    Term Confidence Notes
  • acetylcholine receptor activator activity
    		•  5.9159846946654 bayes_pls_golite062009
  • general RNA polymerase II transcription factor activity
    		•  5.68265749805481 bayes_pls_golite062009
  • phosphotransferase activity, alcohol group as acceptor
    		•  5.49988294224815 bayes_pls_golite062009
  • protein kinase activity
    		•  5.4586557943719 bayes_pls_golite062009
  • kinase activity
    		•  5.3287080791198 bayes_pls_golite062009
  • transferase activity, transferring phosphorus-containing groups
    		•  4.96052051118534 bayes_pls_golite062009
  • cyclin-dependent protein kinase activity
    		•  4.62392503670521 bayes_pls_golite062009
  • protein serine/threonine kinase activity
    		•  4.46381887831481 bayes_pls_golite062009
  • transferase activity
    		•  3.97138602499442 bayes_pls_golite062009
  • structural molecule activity
    		•  3.82327979736517 bayes_pls_golite062009
  • transmembrane receptor protein tyrosine kinase activity
    		•  3.41480681854114 bayes_pls_golite062009
  • transmembrane receptor protein kinase activity
    		•  3.40140621607334 bayes_pls_golite062009
  • protein tyrosine kinase activity
    		•  2.8153155526437 bayes_pls_golite062009
  • phosphoinositide 3-kinase binding
    		•  2.79505438761262 bayes_pls_golite062009
  • binding
    		•  2.74863538127007 bayes_pls_golite062009
  • transmembrane receptor activity
    		•  2.59526003830791 bayes_pls_golite062009
  • ion transmembrane transporter activity
    		•  2.52531786618214 bayes_pls_golite062009
  • cation transmembrane transporter activity
    		•  2.46424348876434 bayes_pls_golite062009
  • signal transducer activity
    		•  2.40586892801446 bayes_pls_golite062009
  • molecular transducer activity
    		•  2.40586892801446 bayes_pls_golite062009
  • receptor activity
    		•  2.39311927684508 bayes_pls_golite062009
  • substrate-specific transmembrane transporter activity
    		•  2.37122853419919 bayes_pls_golite062009
  • histone kinase activity (H3-S10 specific)
    		•  2.30449166929476 bayes_pls_golite062009
  • protein binding
    		•  2.276111749106 bayes_pls_golite062009
  • tubulin binding
    		•  2.18641675163967 bayes_pls_golite062009
  • cytoskeletal protein binding
    		•  2.12615078788254 bayes_pls_golite062009
  • receptor signaling protein activity
    		•  2.10379226653669 bayes_pls_golite062009
  • ATP binding
    		•  1.97600611746091 bayes_pls_golite062009
  • ubiquitin-protein ligase activity
    		•  1.94085498993561 bayes_pls_golite062009
  • adenyl ribonucleotide binding
    		•  1.93596671856664 bayes_pls_golite062009
  • adenyl nucleotide binding
    		•  1.90928021591891 bayes_pls_golite062009
  • metal ion transmembrane transporter activity
    		•  1.9016235206634 bayes_pls_golite062009
  • microtubule binding
    		•  1.88110801192607 bayes_pls_golite062009
  • actin binding
    		•  1.87817875565699 bayes_pls_golite062009
  • receptor signaling protein serine/threonine kinase activity
    		•  1.81249386965144 bayes_pls_golite062009
  • telethonin binding
    		•  1.75733591474207 bayes_pls_golite062009
  • small conjugating protein ligase activity
    		•  1.74206248731815 bayes_pls_golite062009
  • fibroblast growth factor 1 binding
    		•  1.66976264488423 bayes_pls_golite062009
  • purine ribonucleotide binding
    		•  1.65732943334212 bayes_pls_golite062009
  • ribonucleotide binding
    		•  1.65726906484847 bayes_pls_golite062009
  • purine nucleotide binding
    		•  1.63763394711025 bayes_pls_golite062009
  • nucleotide binding
    		•  1.63195828048121 bayes_pls_golite062009
  • insulin receptor substrate binding
    		•  1.62657794525303 bayes_pls_golite062009
  • transcription regulator activity
    		•  1.56748951434625 bayes_pls_golite062009
  • growth factor binding
    		•  1.53863828216563 bayes_pls_golite062009
  • nucleic acid binding
    		•  1.46547714006072 bayes_pls_golite062009
  • JUN kinase kinase kinase activity
    		•  1.45392497707807 bayes_pls_golite062009
  • MAP kinase kinase activity
    		•  1.42275431028856 bayes_pls_golite062009
  • DNA binding
    		•  1.35333135345112 bayes_pls_golite062009
  • ErbB-3 class receptor binding
    		•  1.34841233233438 bayes_pls_golite062009
  • ErbB-2 class receptor binding
    		•  1.33825339298024 bayes_pls_golite062009
  • kinase binding
    		•  1.26086833316556 bayes_pls_golite062009
  • acid-amino acid ligase activity
    		•  1.2266791546014 bayes_pls_golite062009
  • catalytic activity
    		•  1.21655087018101 bayes_pls_golite062009
  • transcription elongation regulator activity
    		•  1.16995153203536 bayes_pls_golite062009
  • transcription repressor activity
    		•  1.14496167267281 bayes_pls_golite062009
  • transporter activity
    		•  1.11833481501707 bayes_pls_golite062009
  • non-membrane spanning protein tyrosine kinase activity
    		•  1.11664317075762 bayes_pls_golite062009
  • transcription factor activity
    		•  1.10928254946881 bayes_pls_golite062009
  • transmembrane receptor protein serine/threonine kinase activity
    		•  1.10045286406485 bayes_pls_golite062009
  • transforming growth factor beta receptor activity
    		•  1.10045286406485 bayes_pls_golite062009
  • protein kinase binding
    		•  1.06030596516506 bayes_pls_golite062009
  • cation channel activity
    		•  1.04999722123563 bayes_pls_golite062009
  • transcription activator activity
    		•  0.997272622653026 bayes_pls_golite062009
  • PTB domain binding
    		•  0.9900774724568 bayes_pls_golite062009
  • transmembrane transporter activity
    		•  0.97575992765505 bayes_pls_golite062009
  • alpha-actinin binding
    		•  0.877087652539674 bayes_pls_golite062009
  • insulin-like growth factor receptor binding
    		•  0.872782211382796 bayes_pls_golite062009
  • fibroblast growth factor binding
    		•  0.870666814073948 bayes_pls_golite062009
  • MAP kinase activity
    		•  0.81943579965027 bayes_pls_golite062009
  • actin filament binding
    		•  0.794152600084 bayes_pls_golite062009
  • fibroblast growth factor receptor activity
    		•  0.75189004129952 bayes_pls_golite062009
  • substrate-specific transporter activity
    		•  0.705905455086486 bayes_pls_golite062009
  • hormone receptor binding
    		•  0.705067960165986 bayes_pls_golite062009
  • beta-catenin binding
    		•  0.693246095477001 bayes_pls_golite062009
  • structural constituent of cytoskeleton
    		•  0.612883428421652 bayes_pls_golite062009
  • cyclin-dependent protein kinase activating kinase activity
    		•  0.529121666062889 bayes_pls_golite062009
  • activin binding
    		•  0.510364757301021 bayes_pls_golite062009
  • steroid hormone receptor binding
    		•  0.505233004492768 bayes_pls_golite062009
  • protein serine/threonine/tyrosine kinase activity
    		•  0.48345772948903 bayes_pls_golite062009
  • enzyme binding
    		•  0.46284745266176 bayes_pls_golite062009
  • protein kinase C activity
    		•  0.41587987561486 bayes_pls_golite062009
  • cyclin-dependent protein kinase regulator activity
    		•  0.406297251827056 bayes_pls_golite062009
  • RNA polymerase II transcription factor activity
    		•  0.401250804041384 bayes_pls_golite062009
  • structural constituent of muscle
    		•  0.399773397398032 bayes_pls_golite062009
  • magnesium ion binding
    		•  0.393328812780268 bayes_pls_golite062009
  • MAP kinase kinase kinase activity
    		•  0.37115026509016 bayes_pls_golite062009
  • structure-specific DNA binding
    		•  0.318153468064373 bayes_pls_golite062009
  • channel activity
    		•  0.287189255116606 bayes_pls_golite062009
  • passive transmembrane transporter activity
    		•  0.287189255116606 bayes_pls_golite062009
  • insulin receptor binding
    		•  0.266450215230107 bayes_pls_golite062009
  • substrate-specific channel activity
    		•  0.261869836686301 bayes_pls_golite062009
  • RNA binding
    		•  0.245748631571068 bayes_pls_golite062009
  • ion channel activity
    		•  0.241519346930618 bayes_pls_golite062009
  • nuclear hormone receptor binding
    		•  0.240883589532225 bayes_pls_golite062009
  • protein complex binding
    		•  0.239339759110451 bayes_pls_golite062009
  • insulin receptor activity
    		•  0.237134032032089 bayes_pls_golite062009
  • SH2 domain binding
    		•  0.226760162354251 bayes_pls_golite062009
  • ligase activity, forming carbon-oxygen bonds
    		•  0.149958560815481 bayes_pls_golite062009
  • ligase activity, forming aminoacyl-tRNA and related compounds
    		•  0.149958560815481 bayes_pls_golite062009
  • aminoacyl-tRNA ligase activity
    		•  0.14842991990838 bayes_pls_golite062009
  • peptide binding
    		•  0.118578378753757 bayes_pls_golite062009
  • transforming growth factor beta receptor activity, type I
    		•  0.0506751594607393 bayes_pls_golite062009
  • nucleoside-triphosphatase activity
    		•  0.0040394359628233 bayes_pls_golite062009
  • brain-derived neurotrophic factor binding
    		•  0.00315481858218991 bayes_pls_golite062009


    Reference: Drew K, et al. (2011) The proteome folding project: Proteome-scale prediction of structure and function. Genome Res. 2011 Sep 16


    Philius Transmembrane Prediction:

    Protein predicted to be: GLOBULAR (No transmembrane regions or signal peptide)
    Confidence of classification: 0.96

    Source: Reynolds et al. (2008)

    YRC Informatics Platform - Version 3.0
    Created and Maintained by: Michael Riffle